Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines

Malgorzata Adamiec-Organisciok; Magdalena Wegrzyn; Lukasz Cienciala; Ngoni Magate; Magdalena Skonieczna; Joanna Nackiewicz

doi:10.5114/pg.2024.134872

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

NOWOŚĆ

Portal dla gastroenterologów!

www.egastroenterologia.pl

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

2/2024
vol. 19

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines

Malgorzata Adamiec-Organisciok

¹

,

Magdalena Wegrzyn

¹

,

Lukasz Cienciala

¹

,

Ngoni Magate

¹

,

Magdalena Skonieczna

¹

,

Joanna Nackiewicz

²

Department of Systems Engineering and Biology, Silesian University of Technology, Faculty of Automatic Control, Electronics and Computer Science, Gliwice, Poland
Faculty of Chemistry, University of Opole, Opole, Poland

Gastroenterology Rev 2024; 19 (2): 112–120

DOI: https://doi.org/10.5114/pg.2024.134872

Data publikacji online: 2024/02/05

Pełna treść artykułu Pobierz cytowanie

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Adamiec-Organisciok M, Wegrzyn M, Cienciala L, Magate N, Skonieczna M, Nackiewicz J. Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):112-120. doi:10.5114/pg.2024.134872.

APA

Adamiec-Organisciok, M., Wegrzyn, M., Cienciala, L., Magate, N., Skonieczna, M.,  & Nackiewicz, J. (2024). Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), 112-120. https://doi.org/10.5114/pg.2024.134872

Chicago

Adamiec-Organisciok, Malgorzata, Magdalena Wegrzyn, Lukasz Cienciala, Ngoni Magate, Magdalena Skonieczna,  and Joanna Nackiewicz. 2024. "Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines". Gastroenterology Review/Przegląd Gastroenterologiczny 19 (2): 112-120. doi:10.5114/pg.2024.134872.

Harvard

Adamiec-Organisciok, M., Wegrzyn, M., Cienciala, L., Magate, N., Skonieczna, M.,  and Nackiewicz, J. (2024). Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), pp.112-120. https://doi.org/10.5114/pg.2024.134872

MLA

Adamiec-Organisciok, Malgorzata et al. "Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 19, no. 2, 2024, pp. 112-120. doi:10.5114/pg.2024.134872.

Vancouver

Adamiec-Organisciok M, Wegrzyn M, Cienciala L, Magate N, Skonieczna M, Nackiewicz J. Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):112-120. doi:10.5114/pg.2024.134872.

Metryki PlumX:

Regulated cell death is a fundamental biological process that plays a crucial role in maintaining tissue homeostasis and eliminating damaged or unnecessary cells. Ferroptosis is an iron-dependent process, characterized by the accumulation of oxidized and damaged lipids, which leads to programmed cell death. Among the ferroptotic pathway genes regulating this process, GPX4, TFRC, ACSL4, FSP1, SLC7A11, and PROM2 could be considered. There are many well-known ferroptotic pathway regulators, which are discussed in this compact review. Cells with tissues of different origin display sensitive or resistant phenotypes to such regulators. In some cases, unexpected changes during cell treatment occurred, suggesting the possibility of regulating the death pathway. We assumed that possible changing of ferro-sensitivity to ferro-resistance in cells, especially in colorectal cancer cell lines, is responded for induced chemoresistance. Using novel techniques, such as CRISPR/Cas-9 genome editing, an induced phenotype “switching” is possible.

Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines

Malgorzata Adamiec-Organisciok 1 , Magdalena Wegrzyn 1 , Lukasz Cienciala 1 , Ngoni Magate 1 , Magdalena Skonieczna 1 , Joanna Nackiewicz 2

Malgorzata Adamiec-Organisciok

¹

,

Magdalena Wegrzyn

¹

,

Lukasz Cienciala

¹

,

Ngoni Magate

¹

,

Magdalena Skonieczna

¹

,

Joanna Nackiewicz

²